rs6596471 — SLC23A1 SLC23A1 variant

SLC23A1 rs6596471 — A Second Independent Haplotype at the Vitamin C Transporter Gene

Your body cannot synthesize vitamin C. Every molecule of ascorbate¹¹ ascorbate
The biologically active, ionized form of ascorbic acid at physiological pH — the form actively transported across cell membranes in your bloodstream was absorbed from food by your intestine and then conserved by your kidneys. Both steps depend on SVCT1²² SVCT1
Sodium-dependent Vitamin C Transporter 1 — encoded by SLC23A1 on chromosome 5q23.2, expressed on the apical membrane of intestinal enterocytes and proximal renal tubule cells, the transporter encoded by SLC23A1. rs6596471 is an intronic variant in this gene that was identified as one of four SLC23A1 variants assessed in a landmark population study of circulating vitamin C concentrations. The G allele represents an independent haplotype effect on transporter function that is distinct from — and likely additive with — the well-characterized Val264Met missense variant at the same gene.

The Mechanism

rs6596471 falls in an intron of SLC23A1 at GRCh38 position chr5:139,369,899. The gene itself sits on the minus strand, but genome files report the plus-strand alleles (A reference, G alternate). Intronic variants exert their effects through regulatory rather than protein-coding mechanisms: they can alter splice enhancer or silencer sequences³³ splice enhancer or silencer sequences
Short sequence motifs within introns that recruit splicing regulatory proteins, influencing how efficiently exons are joined during pre-mRNA processing. Variants in these regions can alter the ratio of functional splice isoforms, intronic secondary promoters, mRNA stability elements, or binding sites for RNA-binding proteins. The net result is a measurable change in SVCT1 protein output at the intestinal epithelium and proximal kidney tubule — reducing both dietary vitamin C absorption and the renal reabsorption that prevents filtered ascorbate from being lost in urine.

The biological importance of SVCT1 is dramatically illustrated by knockout mouse experiments⁴⁴ knockout mouse experiments
Corpe CP et al. Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J Clin Invest, 2010: mice completely lacking Slc23a1 excrete 18 times more ascorbate in urine than controls and 45% of offspring die perinatally. rs6596471 represents a partial perturbation of the same system — measurable, not catastrophic, but clinically relevant at the population level.

The Evidence

rs6596471 was included in the discovery phase of a landmark meta-analysis⁵⁵ landmark meta-analysis
Timpson NJ et al. Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. Am J Clin Nutr, 2010 that pooled data from five independent UK cohorts (15,087 participants total). The paper assessed four variants across the SLC23A1 locus — rs6596471, rs6596473, rs33972313, and rs10063949 — to characterize the genetic architecture of this region. While rs33972313 (Val264Met) emerged as the primary confirmed signal in the pooled meta-analysis (~6 µmol/L reduction per minor allele, P = 2.0×10⁻⁷), the assessment of rs6596471 in the discovery phase reflects its role as a marker for a distinct haplotype class at the locus. Different variants in the same gene can independently tag different functional changes in transporter regulation.

The broader genetic landscape was mapped in a GWAS of 52,018 European individuals⁶⁶ GWAS of 52,018 European individuals
Zheng JS et al. Plasma Vitamin C and Type 2 Diabetes: Genome-Wide Association Study and Mendelian Randomization Analysis in European Populations. Diabetes Care, 2021 that identified 11 genome-wide significant loci for plasma vitamin C — with SLC23A1 producing the strongest signal of any locus. The same locus was independently confirmed in the EPIC cohort study⁷⁷ EPIC cohort study
Duell EJ et al. Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort. Genes Nutr, 2013 (365 gastric cancer cases, 1,284 controls), which found multiple SLC23A1 variants each independently predicting circulating ascorbate concentrations after accounting for dietary intake.

Mendelian randomization studies using SLC23A1 variants as genetic instruments have consistently found that genetically lower vitamin C does not causally drive cardiovascular disease, type 2 diabetes, or other cardiometabolic outcomes — indicating that observational associations between low vitamin C and disease risk largely reflect dietary confounding rather than direct vitamin C deficiency pathology.

Practical Actions

The frequency of the G allele at rs6596471 varies considerably by ancestry: about 25% in Europeans (so GG homozygosity affects ~6% of Europeans) versus 78% in East Asians. For G allele carriers, the practical implication parallels other SLC23A1 variants: reduced SVCT1 efficiency means a higher dietary vitamin C intake is needed to maintain the same plasma ascorbate level as someone with two reference copies. The body cannot compensate by making its own vitamin C — it can only absorb what arrives in the gut and retain what passes through the kidney.

Practical strategies focus on providing more substrate to the transporter (higher dietary intake and supplementation) and on verifying adequacy with plasma ascorbate measurement. Single large doses of supplemental vitamin C are inefficient because intestinal absorption saturates at approximately 200 mg per dose regardless of genotype. Distributing intake across the day is more effective for maintaining plasma levels.

Interactions

rs6596471 operates at the same gene and same physiological step as rs33972313 (the Val264Met missense variant) and rs11950646 (another intronic regulatory signal). These are independent haplotype markers at the SLC23A1 locus: a person carrying risk alleles at multiple positions would be expected to show a larger reduction in SVCT1 output than any single variant alone. Separately, the SLC23A2 gene (which encodes SVCT2, the tissue-level transporter responsible for vitamin C delivery to the brain, adrenal glands, and eyes) harbours its own independent regulatory variants (rs6053005, rs6133175, rs1279683). Carrying risk alleles at both SLC23A1 (absorption + renal reabsorption) and SLC23A2 (tissue delivery) would be expected to produce a compounded reduction in tissue-level vitamin C, though this specific combination has not been directly studied.